(c) 2024 PillSync.com

ramelteon 8 mg

1 INDICATIONS AND USAGE Ramelteon Tablets are indicated for the treatment of insomnia characterized by difficulty with sleep onset. The clinical trials performed in support of efficacy were up to six months in duration. The final formal assessments of sleep latency were performed after two days of treatment during the crossover study (elderly only), at five weeks in the six week studies (adults and elderly), and at the end of the six month study (adults and elderly) [see Clinical Studies (14) ]. Ramelteon Tablets are indicated for the treatment of insomnia characterized by difficulty with sleep onset.

i3 pharmaceuticals, llc


1 year ago ROUND YELLOW 5 I3 ramelteon 8 mg

ROUND YELLOW 5 I3

1 year ago ROUND YELLOW 5 I3 ramelteon 8 mg

5 I3 ROUND YELLOW

16 HOW SUPPLIED/STORAGE AND HANDLING

RAMELTEON Tablets are available as round, yellow, film coated tablets debossed with "I3" on one side and "5" on the other side in the following quantities: NDC 72319-005-01 Bottles of 30 NDC 72319-005-04 Bottles of 100 NDC 72319-005-05 Bottles of 500 Store at 25°C(77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep container tightly closed and protected from moisture and humidity.


More pills like ROUND 5 I3

Related Pills

ramelteon 8 mg

i3 pharmaceuticals, llc












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site